Evidence map›Paper›PMID 25915460›Full record

ReviewMolecules (Basel, Switzerland)2015

Cymbopogon species; ethnopharmacology, phytochemistry and the pharmacological importance.

Opeyemi Avoseh, Opeoluwa Oyedeji, Pamela Rungqu, Benedicta Nkeh-Chungag, Adebola Oyedeji

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. A formulation containingBeilstein journal of nanotechnology · 2025
    Article
  9. Article
  10. Pharmacological basis for medicinal use ofFrontiers in pharmacology · 2025
    Article
  11. Article
  12. Review
  13. Plants (Basel, Switzerland) · 2024
    Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. UtilizingMolecules (Basel, Switzerland) · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Opeyemi AvosehChemistry Department, University of Fort Hare, 5700 Alice, South Africa. seavoseh@gmail.com.
Opeoluwa OyedejiChemistry Department, University of Fort Hare, 5700 Alice, South Africa. ooyedeji@ufh.ac.za.
Pamela RungquChemistry Department, University of Fort Hare, 5700 Alice, South Africa. 200800815@ufh.ac.za.
Benedicta Nkeh-ChungagDepartment of Zoology, Walter Sisulu University, 5099 Mthatha, South Africa. bnkehchungag@wsu.ac.za.
Adebola OyedejiDepartment of Chemistry, Walter Sisulu University, 5099 Mthatha, South Africa. aoyedeji@wsu.ac.za.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cymbopogon genus is a member of the family of Gramineae which are herbs known worldwide for their high essential oil content. They are widely distributed across all continents where they are used for various purposes. The commercial and medicinal uses of the various species of Cymbopogon are well documented. Ethnopharmacology evidence shows that they possess a wide array of properties that justifies their use for pest control, in cosmetics and as anti-inflammation agents. These plants may also hold promise as potent anti-tumor and chemopreventive drugs. The chemo-types from this genus have been used as biomarkers for their identification and classification. Pharmacological applications of Cymbopogon citratus are well exploited, though studies show that other species may also useful pharmaceutically. Hence this literature review intends to discuss these species and explore their potential economic importance.

Indexed as

Anti-Infective AgentsAnti-Inflammatory AgentsAntineoplastic AgentsAntiprotozoal AgentsChemopreventionCymbopogonEthnopharmacologyOils, VolatilePest Control, BiologicalPhytochemicalsPhytotherapyPlant ExtractsAnti-Infective AgentsAnti-Inflammatory AgentsAntineoplastic AgentsAntiprotozoal AgentsOils, VolatilePhytochemicalsPlant Extracts

Identifiers

PMID25915460
PMCPMC6272507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.